880 Stroke Patients in Singapore to Undergo TCM Clinical Trial (Singapore)
This article was originally published in PharmAsia News
Executive Summary
Singapore's National Medical Research Council has initiated the world's largest recorded clinical trial to test a stroke recovery treatment. Over the course of two years, researchers will evaluate the effectiveness of a traditional Chinese medicine known as NeuroAid on patients who have suffered a stroke in the past 48 hours. Neuroaid is already used around the world to support neurological performance. The study will include 1,100 subjects including 880 from Singapore itself. Additional patients will come from Thailand, the Philippines, and possibly Hong Kong. (Click here for more